Pages that link to "Q82210564"

The following pages link to CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma (Q82210564):

Displaying 21 items.

• Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites (Q26798402) (← links)
• Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents (Q26830743) (← links)
• Suppression, subversion and escape: the role of regulatory T cells in cancer progression (Q27026151) (← links)
• The role of chemokines in breast cancer pathology and its possible use as therapeutic targets (Q34069862) (← links)
• High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma (Q34256122) (← links)
• Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer (Q35016950) (← links)
• Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression (Q35384216) (← links)
• Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma (Q35644535) (← links)
• Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients (Q35929374) (← links)
• Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients. (Q36089956) (← links)
• An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth (Q37101126) (← links)
• Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis (Q37295753) (← links)
• A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors. (Q37589128) (← links)
• Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. (Q38702312) (← links)
• Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. (Q39197682) (← links)
• Home sweet home: the tumor microenvironment as a haven for regulatory T cells. (Q43090164) (← links)
• The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4 (Q58600025) (← links)
• CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells (Q60908698) (← links)
• A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages (Q61800971) (← links)
• Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism (Q86838749) (← links)
• Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response (Q90473178) (← links)